Showing results (11-20 of 1,266) with videos related to
Sort By:
Pageof 127
The International Journal of Biological Markers|May 24, 2007
Development and clinical indications of cetuximabR Labianca, N La Verde, M C GarassinoAnnals of Oncology : Official Journal of the European Society for Medical Oncology|July 31, 2007
Increased survival using platinum analog combined with gemcitabine as compared to single-agent gemcitabine in advanced pancreatic cancer: pooled analysis of two randomized trials, the GERCOR/GISCAD intergroup study and a German multicenter studyV Heinemann, R Labianca, A Hinke, et al.Journal of Health Services Research & Policy|January 6, 2000
Evolution of physicians' attitudes towards practice guidelinesR Grilli, R Trisolini, R Labianca, et al.Epidemiologia E Prevenzione|June 5, 1999
[How have opinions of medical oncologists changed regarding compared guidelines? Findings from two surveys conducted in 1993-1997]R Grilli, R Trisolini, R Labianca, et al.Bollettino Dell'Istituto Sieroterapico Milanese|November 30, 1979
Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report)G Luporini, P Fraschini, R Labianca, et al.Seminars in Oncology|November 5, 1997
ICON 2 and ICON 3 data in previously untreated ovarian cancer: results to dateP HarperSeminars in Oncology|August 1, 1997
The role of docetaxel (Taxotere) as a single agent or in combination before local treatment of non-small cell lung cancerP HarperDigestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 18, 2005
Targeted therapy in colorectal cancer: do we know enough?M A Pantaleo, E Palassini, R Labianca, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1996
Modulated 5-fluorouracil (5-FU) regimens in advanced colorectal cancer: a critical review of comparative studiesR Labianca, A Pessi, G Facendola, et al.Pageof 127